Loading patent…
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsRobert Yarchoan, M. Wayne Saville, Giovanna Tosato, Kazuyuki Taga
Estimating the term…
The present invention provides a method of inhibiting the replication of human immunodeficiency virus in cells which are infected with HIV comprising administering to the cells a replication inhibiting amount of interleukin-10. Also provided is a parenteral method of the administration of interleukin-10 administration. Further provided is a method of inhibiting retroviral replication in a human subject infected by a retrovirus, comprising administering to the subject an inhibiting amount of interleukin-10, including the retrovirus is. Finally, a method of treating Kaposi's sarcoma in a human subject comprising administering to the subject an effective amount of interleukin-10 to the subject is provided.
A method of therapeutically inhibiting the replication of human immunodeficiency virus in human cells in or from a human subject comprising administering to the cells a replication inhibiting amount of interleukin-10.
A method of treating a disease caused by human immunodeficiency virus in a human subject comprising administering a replication inhibiting amount of interleukin-10 to the subject.
A method of inhibiting retroviral replication in a human subject infected by a retrovirus comprising administering to the subject an inhibiting amount of interleukin-10.
A method of treating Kaposi's sarcoma in a human subject comprising administering to the subject an effective amount of interleukin-10 to the subject.
Dependencies are inferred from the claim text.